# Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer

> **NCT00103233** · PHASE3 · COMPLETED · sponsor: **SWOG Cancer Research Network**

## Conditions studied

- Breast Cancer

## Interventions

- **BIOLOGICAL:** trastuzumab
- **DRUG:** vinorelbine tartrate

## Key facts

- **NCT ID:** NCT00103233
- **Lead sponsor:** SWOG Cancer Research Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** 2006-04
- **Target enrollment:** — (—)
- **Last updated:** 2013-06-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00103233

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00103233, "Vinorelbine With or Without Trastuzumab in Treating Women With Progressive Metastatic Breast Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00103233. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*